Is Amlodipine + Lisinopril registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Amlodipine + Lisinopril, including LISONORM 10 - 5 (10,5 mg,mg, Tablet, SAR 38.75); LISONORM 20 -10 (20,10 mg,mg, Tablet, SAR 54.40).

Is Amlodipine + Lisinopril on the WHO Model List of Essential Medicines?

Yes — 12.3. Antihypertensive medicines (core list): Essential hypertension.

Active substances

Amlodipine + Lisinopril

SFDA 2
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
LISONORM 10 - 5	10,5 mg,mg	Tablet · Oral use	30 Blister	SAR 38.75	NCE · Prescription	AJA PHARMACEUTICAL INDUSTRIES	Valid
LISONORM 20 -10	20,10 mg,mg	Tablet · Oral use	30 Blister	SAR 54.40	NCE · Prescription	AJA PHARMACEUTICAL INDUSTRIES	Valid

Indications — CHI Daman Drug Formulary

HYPERTENSION

WHO WHO Model List of Essential Medicines (2025)

12.3. Antihypertensive medicines · core
Essential hypertension
Oral > Solid: 10 mg + 5 mg; 20 mg + 5 mg; 20 mg + 10 mg

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.